EA201400834A1 - Система доставки лекарств - Google Patents

Система доставки лекарств

Info

Publication number
EA201400834A1
EA201400834A1 EA201400834A EA201400834A EA201400834A1 EA 201400834 A1 EA201400834 A1 EA 201400834A1 EA 201400834 A EA201400834 A EA 201400834A EA 201400834 A EA201400834 A EA 201400834A EA 201400834 A1 EA201400834 A1 EA 201400834A1
Authority
EA
Eurasian Patent Office
Prior art keywords
delivery system
core
drug delivery
intermediate layer
therapeutically active
Prior art date
Application number
EA201400834A
Other languages
English (en)
Other versions
EA032208B1 (ru
Inventor
Хейкки Лютикянен
Харри Йукарайнен
Original Assignee
Байер Ой
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201400834(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Ой filed Critical Байер Ой
Publication of EA201400834A1 publication Critical patent/EA201400834A1/ru
Publication of EA032208B1 publication Critical patent/EA032208B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Данное изобретение обеспечивает новую систему доставки лекарств для регулируемого высвобождения терапевтически активных веществ с заданной, по существу, неизменной скоростью высвобождения в течение длительного периода времени. Система доставки включает по крайней мере одно ядро, включающее вышеупомянутое(ые) терапевтически активное(ые) вещество(а), по крайней мере одну оболочку, покрывающую ядро, и промежуточный слой, по существу, инертного материала, причем промежуточный слой применяют между ядром и оболочкой или между двумя слоями оболочки.
EA201400834A 2012-01-23 2013-01-22 Система доставки лекарств EA032208B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23
PCT/FI2013/050068 WO2013110856A1 (en) 2012-01-23 2013-01-22 A drug delivery system

Publications (2)

Publication Number Publication Date
EA201400834A1 true EA201400834A1 (ru) 2014-12-30
EA032208B1 EA032208B1 (ru) 2019-04-30

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400834A EA032208B1 (ru) 2012-01-23 2013-01-22 Система доставки лекарств

Country Status (39)

Country Link
US (1) US10500381B2 (ru)
EP (1) EP2806893B1 (ru)
JP (1) JP6236401B2 (ru)
KR (1) KR102004014B1 (ru)
CN (1) CN104144702B (ru)
AR (1) AR089765A1 (ru)
AU (1) AU2013213514B2 (ru)
BR (1) BR112014017834B1 (ru)
CA (1) CA2861947A1 (ru)
CL (1) CL2014001935A1 (ru)
CO (1) CO7020911A2 (ru)
CR (1) CR20140358A (ru)
CU (1) CU24431B1 (ru)
CY (1) CY1120773T1 (ru)
DK (1) DK2806893T3 (ru)
DO (1) DOP2014000171A (ru)
EA (1) EA032208B1 (ru)
EC (1) ECSP14010605A (ru)
ES (1) ES2691635T3 (ru)
HK (1) HK1203802A1 (ru)
HR (1) HRP20181707T1 (ru)
IL (1) IL233599B (ru)
LT (1) LT2806893T (ru)
MX (1) MX355961B (ru)
MY (1) MY172812A (ru)
NZ (1) NZ627461A (ru)
PE (1) PE20141818A1 (ru)
PH (1) PH12014501654A1 (ru)
PL (1) PL2806893T3 (ru)
PT (1) PT2806893T (ru)
RS (1) RS57911B1 (ru)
SG (1) SG11201404032SA (ru)
SI (1) SI2806893T1 (ru)
TR (1) TR201815247T4 (ru)
TW (1) TWI626951B (ru)
UA (1) UA116197C2 (ru)
UY (1) UY34583A (ru)
WO (1) WO2013110856A1 (ru)
ZA (1) ZA201406206B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide
MX368212B (es) * 2014-06-28 2019-09-24 Laboratorios Andromaco S A Ex Inversiones Gruchi S A Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, útil para la prevención de parto prematuro.
JP2019504021A (ja) * 2015-12-21 2019-02-14 バイエル・オーイュー 膣リングを製造する方法
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
JP7242648B2 (ja) 2017-09-27 2023-03-20 バイエル・オサケユキテュア エラストマーマトリックスからの治療活性剤の放出を変更するための方法
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
WO2020172065A1 (en) * 2019-02-19 2020-08-27 Particle Sciences Inc. Compartmentalized drug delivery devices

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE86484T1 (de) * 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
WO2001085132A1 (en) 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
KR20040036928A (ko) 2001-08-31 2004-05-03 쉐링 오와이 약물 전달 시스템
DE10209979A1 (de) * 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
ATE433746T1 (de) 2004-03-12 2009-07-15 Biodel Inc Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
DK1629844T4 (da) 2004-07-13 2012-05-29 Bayer Schering Pharma Oy Retarderet indgivelsessystem med kontrolleret initialudbrud
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
WO2006085335A2 (en) 2005-01-03 2006-08-17 Lupin Limited Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
US20100136090A1 (en) * 2006-11-20 2010-06-03 N.V. Organon; Intervet International B.V. Helically-Shaped Drug Delivery System
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
CN103347496A (zh) * 2010-12-27 2013-10-09 道康宁公司 药物递送分散体以及由其形成的膜

Also Published As

Publication number Publication date
CR20140358A (es) 2014-11-17
TWI626951B (zh) 2018-06-21
DOP2014000171A (es) 2014-08-15
PE20141818A1 (es) 2014-12-18
TW201343204A (zh) 2013-11-01
PT2806893T (pt) 2018-11-09
CY1120773T1 (el) 2019-12-11
CO7020911A2 (es) 2014-08-11
AU2013213514B2 (en) 2017-07-13
ES2691635T3 (es) 2018-11-28
MX355961B (es) 2018-05-07
SG11201404032SA (en) 2014-08-28
CU24431B1 (es) 2019-07-04
JP6236401B2 (ja) 2017-11-22
BR112014017834A8 (pt) 2017-07-11
HK1203802A1 (en) 2015-11-06
PH12014501654B1 (en) 2014-10-13
ZA201406206B (en) 2019-06-26
EA032208B1 (ru) 2019-04-30
ECSP14010605A (es) 2015-12-31
PL2806893T3 (pl) 2019-01-31
BR112014017834A2 (ru) 2017-06-20
US20140350488A1 (en) 2014-11-27
PH12014501654A1 (en) 2014-10-13
KR20140127262A (ko) 2014-11-03
JP2015504083A (ja) 2015-02-05
HRP20181707T1 (hr) 2019-02-22
CL2014001935A1 (es) 2015-04-10
UA116197C2 (uk) 2018-02-26
EP2806893B1 (en) 2018-07-18
US10500381B2 (en) 2019-12-10
CU20140094A7 (es) 2014-11-27
CN104144702B (zh) 2018-03-06
IL233599B (en) 2019-07-31
AR089765A1 (es) 2014-09-17
KR102004014B1 (ko) 2019-07-25
TR201815247T4 (tr) 2018-11-21
CA2861947A1 (en) 2013-08-01
UY34583A (es) 2013-09-02
IL233599A0 (en) 2014-08-31
SI2806893T1 (sl) 2019-02-28
LT2806893T (lt) 2018-12-10
MY172812A (en) 2019-12-12
BR112014017834B1 (pt) 2021-05-18
CN104144702A (zh) 2014-11-12
AU2013213514A1 (en) 2014-08-07
WO2013110856A1 (en) 2013-08-01
DK2806893T3 (en) 2018-11-05
MX2014008906A (es) 2014-08-26
EP2806893A1 (en) 2014-12-03
RS57911B1 (sr) 2019-01-31
NZ627461A (en) 2016-07-29

Similar Documents

Publication Publication Date Title
EA201400834A1 (ru) Система доставки лекарств
HK1226084A1 (zh) 用於治療糖尿病的gip和glp-1受體雙重激動劑
EP2968760A4 (en) Drug cassette, autoinjector, and autoinjector system
EP2968775A4 (en) Drug cassette, autoinjector, and autoinjector system
CL2013000020A1 (es) Metodo para controlar una plaga de insectos coleopteros que comprende suministrar a una plaga de coleopteros o su entorno una composicion que contiene al menos una proteina activa contra colepteros, tal como la proteina cry3a modificada activa contra lepidopteros, tal como la proteina cry1ab
MX2015012933A (es) Micrordenamiento para suministro de agente terapeutico y metodos de uso.
EP3578171A4 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCE CARRIER
EP3583218A4 (en) TARGETED ACTIVE SUBSTANCE RELEASE ON LIGAND PAYLOAD BASIS FOR CELL THERAPY
DK2651410T3 (da) Transdermalt terapeutisk system til administration af et aktivstof
EP3377009A4 (en) POROUS STRUCTURES FOR PROLONGED RELEASE MEDICATION DELIVERY DEVICES
WO2012106427A3 (en) Methods for treating diabetic foot ulcers
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
EP3046582A4 (en) Uses of modified mullerian inhibiting substance (mis) proteins for the treatment of neurodegenerative diseases
EP3880175A4 (en) TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM
EP3441080A4 (en) PHARMACEUTICAL COMPOSITION FOR HEALING WOUNDS CONTAINING SUBSTANCE P
EP3162363A4 (en) Composite preparation comprising active ingredient-containing film coating layer
EP3095476A4 (en) Syringe for injecting drug solution into upper skin layer
EP3600014A4 (en) METHODS, DEVICES AND SYSTEM FOR PROVIDING DIAGNOSIS AND THERAPY FOR DIABETIC CONDITION
EA201600387A1 (ru) Дисперсная система доставки лекарственного вещества
EP3743048A4 (en) COLLAGENASE-LOADED LIPOSOMES TO IMPROVE DRUG DELIVERY
EP3720422A4 (en) LIPOSOMAL SYSTEM FOR DRUG DELIVERY
EP3843712A4 (en) METHOD FOR MANUFACTURING ACTIVE DRUG SUBSTANCE OF PIBRENTASVIR
EP3508474A4 (en) INNOVATIVE THERAPEUTIC ACTIVE SUBSTANCE FOR DIABETES
TH153173A (th) ระบบการนำส่งยา
EP3646886A4 (en) TREATMENT OF PAIN WITH A SERONTON-3 RECEPTOR AGONIST

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG TJ TM